SEC 13F Intelligence

Managers / Q3 2019 · view latest →

Granite Point Capital Management, L.P.

CIK 0001599562 · 109 STATE STREET, 5TH FLOOR, BOSTON, MA, 02109 · 617-587-7507

Reported Value
$639M
Q3 2019
Positions
68
Filings on Record
19
2019–present window
Filed
Oct 30, 2019
original filing

Summary

Granite Point Capital Management, L.P. reported $639M in U.S.-listed holdings across 68 positions for Q3 2019.

Its largest position, META, represents 1.1% of the portfolio.

Compared with Q2 2019, the fund opened 14 new positions and exited 29.

Portfolio Metrics

Turnover
+3.3%
vs prior filed quarter
Top-10 Concentration
+7.1%
share of reported value
Largest Position
+1.1%
Facebook
New / Exited
14 / 29
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $1.0BQ1 ’19Q2 ’19: $1.5BQ3 ’19: $639MQ4 ’19: $641MQ4 ’19Q1 ’20: $177MQ2 ’20: $2.0BQ3 ’20: $1.8BQ3 ’20Q4 ’20: $1.9BQ1 ’21: $2.7BQ2 ’21: $2.7BQ2 ’21Q3 ’21: $1.3BQ4 ’21: $590MQ1 ’22: $479MQ1 ’22Q2 ’22: $392MQ3 ’22: $247MQ4 ’22: $157MQ4 ’22Q1 ’23: $72MQ3 ’23: $0filingsflow.com

Portfolio Composition

By security type
ETP: 60.0%Other: 24.8%Common Stock: 11.2%ADR: 3.2%US DOMESTIC: 0.7%
  • ETP · 60.0% · $384M
  • Other · 24.8% · $159M
  • Common Stock · 11.2% · $72M
  • ADR · 3.2% · $20M
  • US DOMESTIC · 0.7% · $5M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
FIVEFIVE BELOW INCNEW+20.0K20.0K+$3M$3M
ELFE L F BEAUTY INCNEW+100.0K100.0K+$2M$2M
XCUREXICURE INCNEW+675.0K675.0K+$2M$2M
ZUMZZUMIEZ INCNEW+50.0K50.0K+$2M$2M
DECIPHERA PHARMACEUTICALS INNEW+42.0K42.0K+$1M$1M
SDCCQSMILEDIRECTCLUB INCNEW+90.8K90.8K+$1M$1M
AAPLAPPLE INCNEW+5.0K5.0K+$1M$1M
LOVELOVESAC COMPANYNEW+50.0K50.0K+$934,000$934,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2019

59 positions (from 60 filing rows — )
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1METAFACEBOOK INChistory →CL A1.15%$7M41.3K
2MARINUS PHARMACEUTICALS INCCOM0.85%$5M3.54M
3MOMO INCADR0.83%$5M171.0K
4GOOGLALPHABET INCCAP STK CL A0.76%$5M4.0K
5TILRAY INCDEBT 5.000%10/00.71%$5M7.00M
6EVERBRIDGE INCCOM0.59%$4M61.0K
7SIENTRA INCCOM0.57%$4M566.4K
8AMDADVANCED MICRO DEVICES INCNOTE 2.125% 9/0 · COM0.56%$4M560.0K
9BOOTBOOT BARN HLDGS INCCOM0.55%$3M99.8K
10ZOGENIX INCCOM NEW0.54%$3M86.6K
11BABAALIBABA GROUP HLDG LTDSPONSORED ADS0.52%$3M20.0K
12AMZNAMAZON COM INCCOM0.52%$3M1.9K
13SESEA LTDSPONSORED ADS0.49%$3M102.0K
14ZENDESK INCCOM0.46%$3M40.0K
15XENEXENON PHARMACEUTICALS INCCOM0.42%$3M296.5K
16FIVEFIVE BELOW INCCOM0.39%$3M20.0K
17DIREXION SHS ETF TRCSI 300 BULL2X0.39%$2M122.3K
18TNDMTANDEM DIABETES CARE INCCOM NEW0.39%$2M42.0K
19LULULULULEMON ATHLETICA INCCOM0.37%$2M12.2K
20KRANESHARES TRCSI CHI INTERNET0.33%$2M51.7K
21LUMENTUM HLDGS INCNOTE 0.250% 3/10.31%$2M1.70M
22ELFE L F BEAUTY INCCOM0.27%$2M100.0K
23XCUREXICURE INCCOM0.27%$2M675.0K
24ZUMZZUMIEZ INCCOM0.25%$2M50.0K
25DQDAQO NEW ENERGY CORPSPNSRD ADR NEW0.24%$2M33.7K
26LXLEXINFINTECH HLDGS LTDADR0.23%$1M144.9K
27DECIPHERA PHARMACEUTICALS INCOM0.22%$1M42.0K
28GOOSCANADA GOOSE HOLDINGS INCSHS SUB VTG0.22%$1M32.0K
29CDNACAREDX INCCOM0.22%$1M61.2K
30BILIBILIBILI INCSPONS ADS REP Z0.21%$1M94.0K
31SDCCQSMILEDIRECTCLUB INCCL A COM0.20%$1M90.8K
32AGXARGAN INCCOM0.18%$1M30.0K
33OVIDOVID THERAPEUTICS INCCOM0.18%$1M348.3K
34AAPLAPPLE INCCOM0.18%$1M5.0K
35CRESCENT ACQUISITION CORPUNIT 99/99/99990.16%$1M100.0K
36TALTAL EDUCATION GROUPSPONSORED ADS0.15%$990,00028.9K
37MATINAS BIOPHARMA HLDGS INCCOM0.15%$946,0001.50M
38JTUSDJIANPU TECHNOLOGY INCADR0.15%$943,000377.2K
39LOVELOVESAC COMPANYCOM0.15%$934,00050.0K
40AFYA LTDCL A COM0.12%$749,00029.2K
41WBWEIBO CORPSPONSORED ADR0.11%$716,00016.0K
42RNGRINGCENTRAL INCCL A0.11%$694,0005.5K
43MAGNACHIP SEMICONDUCTOR SANOTE 5.000% 3/00.11%$687,000500.0K
44NEW ORIENTAL ED & TECH GRP ISPON ADR0.10%$665,0006.0K
45MOTUS GI HLDGS INCCOM0.10%$660,000333.3K
46AXGNAXOGEN INCCOM0.10%$624,00050.0K
47AERIE PHARMACEUTICALS INCCOM0.09%$577,00030.0K
48BEASLEY BROADCAST GROUP INCCL A0.08%$540,000174.2K
49NKENIKE INCCL B0.07%$470,0005.0K
50DMACDIAMEDICA THERAPEUTICS INCCOM NEW0.07%$470,000227.2K
51YYEURYY INCSPONSORED ADS A0.07%$469,0008.3K
52ACMRACM RESEARCH INCCOM CL A0.07%$454,00032.7K
53VIPSVIPSHOP HLDGS LTDSPONSORED ADS A0.07%$446,00050.0K
54ROKUROKU INCCOM CL A0.06%$407,0004.0K
55CHANGYOU COM LTDADS REP CL A0.06%$370,00039.0K
56STOKSTOKE THERAPEUTICS INCCOM0.06%$365,00017.0K
57EVHEVOLENT HEALTH INCCL A0.06%$360,00050.0K
58GLOBAL EAGLE ENTMT INCNOTE 2.750% 2/10.04%$242,000500.0K
59SOHUSOHU COM LTDSPONSORED ADS0.03%$203,00020.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2023$01Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023Under review1Aug 10, 202313F-HRchanges · EDGAR ↗
Q1 2023$72M52May 11, 202313F-HRchanges · EDGAR ↗
Q4 2022$157M90Feb 7, 202313F-HRchanges · EDGAR ↗
Q3 2022$247M103Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$392M108Aug 5, 202213F-HRchanges · EDGAR ↗
Q1 2022$479M125May 11, 202213F-HRchanges · EDGAR ↗
Q4 2021$590M127Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.3B182Nov 10, 202113F-HRchanges · EDGAR ↗
Q2 2021$2.7B212Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$2.7B254May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.9B150Feb 5, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.8B164Nov 6, 202013F-HRchanges · EDGAR ↗
Q2 2020$2.0B140Aug 12, 202013F-HRchanges · EDGAR ↗
Q1 2020$177M72May 12, 202013F-HRchanges · EDGAR ↗
Q4 2019$641M88Feb 10, 202013F-HRchanges · EDGAR ↗
Q3 2019$639M68Oct 30, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.5B88Jul 29, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.0B108May 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.